Targeting angiogenesis in lung cancer - Pitfalls in drug development.
about
Biomarkers of evasive resistance predict disease progression in cancer patients treated with antiangiogenic therapies.DNA Aptamers for the Characterization of Histological Structure of Lung Adenocarcinoma.Synergies of Targeting Tumor Angiogenesis and Immune Checkpoints in Non-Small Cell Lung Cancer and Renal Cell Cancer: From Basic Concepts to Clinical Reality.
P2860
Targeting angiogenesis in lung cancer - Pitfalls in drug development.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting angiogenesis in lung cancer - Pitfalls in drug development.
@en
type
label
Targeting angiogenesis in lung cancer - Pitfalls in drug development.
@en
prefLabel
Targeting angiogenesis in lung cancer - Pitfalls in drug development.
@en
P2093
P2860
P1476
Targeting angiogenesis in lung cancer - Pitfalls in drug development.
@en
P2093
Andreas Pircher
Christian Manegold
Wolfgang Hilbe
P2860
P304
P356
10.3978/J.ISSN.2218-6751.2012.01.01
P577
2012-06-01T00:00:00Z